Loading...
XJPX
4524
Market cap54mUSD
Jul 10, Last price  
2,170.00JPY
1D
0.05%
1Q
-2.25%
Jan 2017
-20.95%
Name

Morishita Jintan Co Ltd

Chart & Performance

D1W1MN
XJPX:4524 chart
P/E
14.11
P/S
0.70
EPS
153.84
Div Yield, %
2.54%
Shrs. gr., 5y
0.11%
Rev. gr., 5y
6.12%
Revenues
12.69b
-0.61%
9,782,000,0009,427,000,0009,563,000,00011,359,000,00012,406,000,00012,766,000,00012,688,000,000
Net income
628m
+14.81%
322,000,000206,000,000283,000,000491,000,000697,000,000547,000,000628,000,000
CFO
1.15b
+71.90%
804,000,000871,000,000543,000,0001,179,000,000196,000,000669,000,0001,150,000,000
Dividend
Mar 30, 202665 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Morishita Jintan Co., Ltd. is a Japanese enterprise that manufactures and distributes a diverse array of products, encompassing pharmaceuticals, quasi-pharmaceuticals, medical devices, and food items. The company's operations are divided into two main segments: Healthcare Business and Capsule Business. The Healthcare Business division is responsible for the production and sale of its proprietary Jintan branded goods, and also provides original equipment manufacturing (OEM) services for dietary supplements, cosmetic products, and various food items. Concurrently, the Capsule Business division handles both original equipment and design manufacturing (OEM/ODM) for pharmaceutical and food sectors, in addition to innovating and developing capsules for industrial applications. Established in 1893, the company's headquarters are located in Osaka, Japan.
IPO date
Oct 02, 1961
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT